• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Massachusetts General Hospital to Co-Develop VR Digital Therapeutic for Stem Cell Patients

by Jasmine Pennic 03/02/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Massachusetts General Hospital to Co-Develop VR Digital Therapeutic for Stem Cell Patients

What You Should Know:

– Massachusetts General Hospital (“MGH”) announced a research agreement with Rocket VR Health, an emerging digital therapeutics company developing clinically validated virtual reality therapies that enhance the quality of life of cancer patients, their families and their caregivers.

– The research will study the effects of daily Virtual Reality Therapy’s effect on patients during their entire hospital stay.

Partnership Details

The average hospital length of stay for patients with hematologic malignancies who undergo HCT is approximately 28 days. During this intense hospitalization period, patients can’t leave their rooms as their immune system is weakened while their bone marrow is re-generated. As a result, with no contact with the outside world, these patients endure significant short-term and long-term distress that affects their quality of life (QOL) and their physical and psychological well-being – both in the near term and long-term.

As part of the agreement, Rocket VR Health will leverage its virtual reality therapy platform to co-develop a VR digital therapeutic solution based on population-specific well-researched care interventions created by Massachusetts General Hospital. This Digital Therapeutic Solution is intended to help with distress management in blood cancer patients undergoing hematopoietic stem cell transplantation (HCT) in an in-clinic setting. HCT can be used to treat certain types of cancer, such as leukemia, myeloma, and lymphoma, and other blood and immune system diseases that affect the bone marrow.

The treatment being developed consists of 7 modules integrating psychoeducation, therapy and relaxation exercises offered over a 4-week period in beautiful virtual reality (VR) environments designed to be self-administered by patients while they are in their transplant rooms after an initial assistance and on-boarding help from a nurse or other healthcare professional. The immersive environments, imagery, sounds and music included in the Rocket VR Health platform allow patients to access the outside world virtually while being confined to their hospital room.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: cancer, Caregivers, Digital Therapeutics, Virtual Reality

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Redesign Health Study: 71% of Health Systems Adopt an "Epic-First" AI Purchasing Strategy

Redesign Health Study: 71% of Health Systems Adopt an “Epic-First” AI Purchasing Strategy

iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |